Skip to main content

Advertisement

Log in

How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Background. Tamoxifen has been shown to reduce the incidence of invasive breast cancer in women at higher risk. Translating these research results to clinical practice is challenging. Our objective was to develop and evaluate a decision-making guide and process that can be used in clinical practice to inform eligible women of chemoprevention with tamoxifen.

Methods. A decision guide explaining the benefits and risks of tamoxifen was developed with input from health care professionals and two focus groups of women both with and without cancer. Following consent, 51 eligible women presenting to a multi-disciplinary diagnostic facility for breast problems were given the decision guide/questionnaire to read, fill out and return by mail. Women with further questions or wanting to take tamoxifen were encouraged to re-contact their physicians.

Results. Atypia was seen in 60% of subjects. Median 5-year Gail risk was 3.7 (range 1.7–9.4). Only 6 (11.8% 95% CI = 2.9, 20.6%) women reported they would like to take tamoxifen while 6 (11.8% 95% CI = 2.9, 20.6%) remained uncertain.

Conclusion. We have developed a decision-making guide and process that is acceptable to providers and women to identify and inform women at higher risk of breast cancer with regard to chemoprevention with tamoxifen. Few women in this select group, when provided with a balanced decision guide, wished to pursue chemoprevention with tamoxifesn

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. B Fisher JP Costantino DL Wickerham CK Redmond M Kavanah WM Cronin V Vogel A Robidoux N Dimitrov J Atkins M Daly S Wieand E Tan-Chiu L Ford N Wolmark (1998) ArticleTitleTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371–1388 Occurrence Handle10.1093/jnci/90.18.1371 Occurrence Handle9747868

    Article  PubMed  Google Scholar 

  2. M Levine JM Moutquin R Walton J Feightner (2001) ArticleTitleChemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative’s Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer CMAJ 164 1681–1690 Occurrence Handle11450210

    PubMed  Google Scholar 

  3. U.S. Preventative Services Task Force: Chemoprevention of Breast Cancer. http://www ahrq gov/clinic/3rduspstf/breastchemo/ 1–7–2002

  4. B Fisher (2000) ArticleTitleRe: tamoxifen prevention of breast cancer: an instance of the fingerpost J Natl Cancer Inst 92 659–660 Occurrence Handle10.1093/jnci/92.8.659 Occurrence Handle10772691

    Article  PubMed  Google Scholar 

  5. AM O’Connor (1989) ArticleTitleEffects of framing and level of probability on patients’ preferences for cancer chemotherapy J Clin Epidemiol 42 119–126 Occurrence Handle10.1016/0895-4356(89)90085-1 Occurrence Handle2918321

    Article  PubMed  Google Scholar 

  6. ML Slevin L Stubbs HJ Plant P Wilson WM Gregory PJ Armes SM Downer (1990) ArticleTitleAttitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public BMJ 300 1458–1460 Occurrence Handle2379006

    PubMed  Google Scholar 

  7. ER Port LL Montgomery AS Heerdt PI Borgen (2001) ArticleTitlePatient reluctance toward tamoxifen use for breast cancer primary prevention Ann Surg Oncol 8 580–585 Occurrence Handle11508619

    PubMed  Google Scholar 

  8. J Tchou N Hou A Rademaker VC Jordan M Morrow (2004) ArticleTitleAcceptance of tamoxifen chemoprevention by physicians and women at risk Cancer 100 1800–1806 Occurrence Handle10.1002/cncr.20205 Occurrence Handle15112259

    Article  PubMed  Google Scholar 

  9. MH Gail LA Brinton DP Byar DK Corle SB Green C Schairer JJ Mulvihill (1989) ArticleTitleProjecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 1879–1886 Occurrence Handle2593165

    PubMed  Google Scholar 

  10. S Woloshin LM Schwartz S Byram B Fischhoff HG Welch (2000) ArticleTitleA new scale for assessing perceptions of chance: a validation study Med Decis Making 20 298–307 Occurrence Handle10929852

    PubMed  Google Scholar 

  11. BK Rimer JM Schildkraut C Lerman TH Lin J Audrain (1996) ArticleTitleParticipation in a women’s breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium Cancer 77 2348–2355 Occurrence Handle10.1002/(SICI)1097-0142(19960601)77:11<2348::AID-CNCR25>3.0.CO;2-W Occurrence Handle8635106

    Article  PubMed  Google Scholar 

  12. C Lerman B Trock BK Rimer A Boyce C Jepson PF Engstrom (1991) ArticleTitlePsychological and behavioral implications of abnormal mammograms Ann Intern Med 114 657–661 Occurrence Handle2003712

    PubMed  Google Scholar 

  13. DA Dillman (1978) Mail and Telephone Surveys: The Total Design Method Wiley New York

    Google Scholar 

  14. D Stacey AM O’Connor C DeGrasse S Verma (2003) ArticleTitleDevelopment and evaluation of a breast cancer prevention decision aid for higher-risk women Health Expect 6 3–18 Occurrence Handle10.1046/j.1369-6513.2003.00195.x Occurrence Handle12603624

    Article  PubMed  Google Scholar 

  15. C Zimmermann C Baldo A Molino (2000) ArticleTitleFraming of outcome and probability of recurrence: breast cancer patients’ choice of adjuvant chemotherapy (ACT) in hypothetical patient scenarios Breast Cancer Res Treat 60 9–14 Occurrence Handle10.1023/A:1006342316373 Occurrence Handle10845804

    Article  PubMed  Google Scholar 

  16. MN Levine A Gafni B Markham D MacFarlane (1992) ArticleTitleA bedside decision instrument to elicit a patient’s preference concerning adjuvant chemotherapy for breast cancer Ann Intern Med 117 53–58 Occurrence Handle1596048

    PubMed  Google Scholar 

  17. RP McQuellon HB Muss SL Hoffman G Russell B Craven SB Yellen (1995) ArticleTitlePatient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer J Clin Oncol 13 858–868 Occurrence Handle7707112

    PubMed  Google Scholar 

  18. AM O’Connor NF Boyd P Warde L Stolbach JE Till (1987) ArticleTitleEliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences J Chronic Dis 40 811–818 Occurrence Handle10.1016/0021-9681(87)90133-0 Occurrence Handle3597681

    Article  PubMed  Google Scholar 

  19. SB Yellen DF Cella WT Leslie (1994) ArticleTitleAge and clinical decision making in oncology patients J Natl Cancer Inst 86 1766–1770 Occurrence Handle7966414

    PubMed  Google Scholar 

  20. A Veronesi MA Pizzichetta MA Ferlante M Zottar MD Magri D Crivellari S Foladore (1998) ArticleTitleTamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatment Tumori 84 372–375 Occurrence Handle9678620

    PubMed  Google Scholar 

  21. JA Tangrea (1997) ArticleTitlePatient participation and compliance in cancer chemoprevention trials: issues and concerns Proc Soc Exp Biol Med 216 260–265 Occurrence Handle9349695

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew McKay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McKay, A., Martin, W. & Latosinsky, S. How Should We Inform Women at Higher Risk of Breast Cancer About Tamoxifen? An Approach with a Decision Guide. Breast Cancer Res Treat 94, 153–159 (2005). https://doi.org/10.1007/s10549-005-6932-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-6932-6

Keywords

Navigation